Women with HER2+ breast tumors who receive combination therapy unlikely to have cance

[News]

In a new study, women with relatively small, HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted therapy following surgery or radiation therapy were very unlikely to have the cancer recur within a few years of treatment, investigators at Dana-Farber Cancer Institute and other research centers will report at the 2013 San Antonio Breast Cancer Symposium.

More... (http://www.news-medical.net/news/20131212/Women-with-HER22b-breast-tumors-who-receive-combination-therapy-unlikely-to-have-cancer-recur.aspx)